The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.
OBJECTIVE: To compare prostate carcinoma, with and with no lymph node metastasis, to benign prostatic hyperplasia (BPH) tissue for lymphatic vessel density (LVD) and the expression of the lymph-endothelial specific growth factor, vascular endothelial growth factor C (VEGF-C), to determine their role...
Main Authors: | Trojan, L, Rensch, F, Voss, M, Grobholz, R, Weiss, C, Jackson, D, Alken, P, Michel, MS |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
by: Trojan, L, et al.
Published: (2004) -
EWING SARCOMA: FEATURES OF LYMPHOGENOUS METASTASIS AND PROGNOSTIC FACTORS
by: N. V. Vasilyev, et al.
Published: (2019-11-01) -
Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
by: Von Marschall, Z, et al.
Published: (2005) -
LOGISTICS OF LYMPHOGENIC BREAST CANCER METASTASIS
by: Sh. Kh. Gantsev, et al.
Published: (2017-01-01) -
The expression of vascular endothelial growth factor-C correlates with lymphatic microvessel density and lymph node metastasis in prostate carcinoma: An immunohistochemical study
by: Gyftopoulos Kostis, et al.
Published: (2014-01-01)